Page last updated: 2024-10-25

clobenpropit and Breast Neoplasms

clobenpropit has been researched along with Breast Neoplasms in 1 studies

clobenpropit: histamine H3 receptor antagonist
clobenpropit : An imidothiocarbamic ester that consists of isothiourea bearing S-3-(imidazol-4-yl)propyl and N-4-chlorobenzyl substituents. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Medina, V1
Croci, M1
Crescenti, E1
Mohamad, N1
Sanchez-Jiménez, F1
Massari, N1
Nuñez, M1
Cricco, G1
Martin, G1
Bergoc, R1
Rivera, E1

Other Studies

1 other study available for clobenpropit and Breast Neoplasms

ArticleYear
The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
    Cancer biology & therapy, 2008, Volume: 7, Issue:1

    Topics: Adult; Aged; Breast; Breast Neoplasms; Cell Movement; Cell Proliferation; Female; Histamine; Histidi

2008